Repeat surfactant therapy for postsurfactant slump

Journal of Perinatology

Volumn 26, Issue 7, 2006, Pages 414-422

  Katz, L A ^a   Klein, Jonathan M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Extremely low birth weight infants; Postsurfactant slump; Premature infants; Respiratory distress syndrome; Surfactant

Indexed keywords

STEROID; SURFACTANT;

COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OUTCOME ASSESSMENT; PATIENT CODING; PREMATURITY; PRENATAL CARE; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; STEROID THERAPY;

HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LOGISTIC MODELS; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33745679566     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7211533     Document Type: Review

References (19)

1. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: A randomized clinical trial. Pediatrics 1985; 76: 145-153.
2. Hoekstra RE, Jackson JC, Myers TF, Frantz III ID, Stern ME, Powers WF et al. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatics 1991; 88: 10-16.
3. Smyth JA, Metcalfe IL, Duffty P, Possmayer F, Bryan MH, Enhorning G. Hyaline membrane disease treated with bovine surfactant. Pediatics 1983; 71: 913-917.
4. Sobel DB, Carroll A. Postsurfactant slump: Early prediction of neonatal chronic lung disease. J Perinatol 1994; 14: 268-274.
5. Clark RH, Gerstmann DR, Jobe AH, Moffitt ST, Slutsky AS, Yoder BA. Lung injury in neonates: Causes, strategies for prevention, and long-term consequences. J Pediatr 2001; 139: 478-486.
6. Curley AE, Sweet DG, Thornton CM, O'Hara MD, Chesshyre E, Pizzotti J et al. Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: Implications for antenatal origins of chronic lung disease. Am J Obstet Gynecol 2003; 188: 871-875.
7. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002; 140: 171-176.
8. Merrill JD, Ballard RA, Cnaan A, Hibbs AM, Godinez RI, Godinez MH et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 2004; 56: 918-926.
9. Pandit PB, Dunn MS, Kelly EN, Perlman M. Surfactant replacement in neonates with early chronic lung disease. Pediatics 1995; 95: 851-854.
10. Bissinger R, Carlson C, Hulsey T, Eicher D. Secondary surfactant deficiency in neonates. J Perinatol 2004; 24: 663-666.
11. Bloom BT, Kattwinkel J, Hall RT, Delmore PM, Egan EA, Trout JR et al. Comparison of Infasurf (calf lung surfactant extract) to Survanta (beractant) in the treatment and prevention of respiratory distress syndrome. Pediatics 1997; 100: 31-38.
12. Hall SB, Venkitaraman AR, Whitsett JA, Holm BA, Notter RH. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Am Rev Respir Dis 1992; 145: 24-30.
13. Seeger W, Grube C, Gunther A, Schmidt R. Surfactant inhibition by plasma proteins: Differential sensitivity of various surfactant preparations. Eur Respir J 1993; 6: 971-977.
14. Beresford MW, Shaw NJ. Bronchoalveolar lavage surfactant protein A, B, and D concentrations in preterm infants ventilated for respiratory distress syndrome receiving natural and synthetic surfactants. Pediatr Res 2003; 53: 663-670.
15. Taeusch HW, Keough KMW. Inactivation of pulmonary surfactant and the treatment of acute lung injuries. Pediatr Pathol Molec Med 2001; 20: 519-536.
16. Poynter SE, LeVine AM. Surfactant biology and clinical application. Crit Care Clin 2003; 19: 459-472.
17. Muller B, Garn H, Hochscheid R. Impaired recycling of surfactant-like liposomes in type ii pneumocytes from injured lungs. Thorax 2003; 58: 127-134.
18. Herting E, Moller O, Schiffmann JH, Robertson B. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome. Acta Paediatr 2002; 91: 1174-1178.
19. Greenough A. Expanded use of surfactant replacement therapy. Eur J Pediatr 2000; 159: 635-640.